Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Apr 13;12:707–717. doi: 10.2147/OPTH.S150816

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Thygesen. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Hyperemia in patients receiving preservative-added or preservative-free glaucoma medication.

Notes: A multicenter, single-blind, parallel-group study compared the safety and efficacy of preservative-added and preservative-free latanoprost eye drops in 463 patients with glaucoma or ocular hypertension. The graph shows the proportion of patients with moderate or severe conjunctival hyperemia during 84 days of treatment (**p<0.01). Adapted by permission from BMJ Publishing Group Ltd. Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma, Rouland JF, Traverso CE, Stalmans I, et al; T2345 Study Group. 97(2):196–200. © 2013.³⁴